Patent Term Extension Application for TRYNGOLZA™ (olezarsen), Patent No. 9,163,239 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2025-E-0500

Patent Term Extension Application for TRYNGOLZA™ (olezarsen), Patent No. 9,163,239

Documents

Comments

Description

Open

Comment Period OpensFeb 28, 2025

Comment Period ClosesApr 28, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; TRYNGOLZA FR Doc: 2026-03850	Feb 26, 2026	--

CDER

Patent Term Extension Application

Patent No. 9,163,239

TRYNGOLZA™ (olezarsen)

Ionis Pharmaceuticals, Inc.

Cooley LLP

Open